CYP2B6*6 genotype specific differences in artemether‐lumefantrine disposition in healthy volunteers
<p>Cytochrome P450 2B6 (CYP2B6) is involved in the metabolism of the antimalarial drugs artemether and lumefantrine. Here we investigated the effect of <em>CYP2B6</em>*6 on the plasma pharmacokinetics of artemether, lumefantrine, and their metabolites in healthy volunteers...
Autores principales: | Abdullahi, ST, Soyinka, JO, Olagunju, A, Bolarinwa, RA, Olarewaju, OJ, Bakare-Odunola, MT, Winterberg, M, Tarning, J, Owen, A, Khoo, S |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
Wiley
2019
|
Ejemplares similares
-
Differential impact of nevirapine on artemether-lumefantrine pharmacokinetics in individuals stratified by CYP2B6 c.516G>T genotypes
por: Abdullahi, ST, et al.
Publicado: (2020) -
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
por: Ali, S, et al.
Publicado: (2010) -
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
por: Tarning Joel, et al.
Publicado: (2010-10-01) -
Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
por: Walimbwa, S, et al.
Publicado: (2018) -
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
por: Sileshi Belew, et al.
Publicado: (2020-04-01)